COVID-19 Vaccination in Scotland

On the 08 December 2020, a Coronavirus (COVID-19) vaccine developed by Pfizer BioNTech was first used in the UK as part of national immunisation programmes. The AstraZeneca vaccine was also approved for use in the national programme, and rollout of this vaccine began on 04 January 2021. Moderna vaccine was approved for use on 8 January 2021 and rollout of this vaccine began on 07 April 2021.

These vaccines have met strict standards of safety, quality and effectiveness set out by the independent Medicines and Healthcare Products Regulatory Agency (MHRA). Further candidate vaccines continue to be developed, and will be considered under the same processes when available. The aim of the current vaccination programme is to protect those who are at most risk from serious illness or death from COVID-19.

Those giving the vaccine to others have been the first to receive the vaccination. In the first phase of the programme, NHS Scotland will follow the independent advice received from the Joint Committee on Vaccination and Immunisation (JCVI) and deliver the vaccine to those with the greatest clinical need, in line with the recommended order of prioritisation. These are:

• residents in a care home for older adults and their carers,

• all those 80 years of age and over,

• frontline health and social care workers,

• all those 75 years of age and over,

• all those 70 years of age and over,

• clinically extremely vulnerable individuals. This advice on vaccination does not include pregnant women and those under the age of 16 years

• all those 65 years of age and over,

• all individuals aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality,

• unpaid carers,

• all those 60 years of age and over,

• all those 55 years of age and over,

• all those 50 years of age and over.

Individuals can appear in more than one JCVI priority group.

Definitions used in the vaccine uptake by JCVI priority group resource can be found in the JCVI Priority Group Definitions table.

A 2-dose schedule is advised for the vaccines. For the Pfizer BioNTech vaccine, the second vaccine dose can be offered between 3 to 12 weeks after the first dose. For the AstraZeneca and Moderna vaccine, the second dose can be offered 4 to 12 weeks after the first dose.

This dataset provides information on daily number of COVID vaccinations in Scotland. Data on the total number of vaccinations in Scotland is presented by day administered and vaccine type, by age group, by sex, by non age cohorts and by geographies (NHS Board and Local Authority). As the population in the cohorts can change with time, these will be refined on a monthly basis.

Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households and information on immunisation and screening, can be found on NHS Inform.

Data visualisation and additional notes are available on the Public Health Scotland - Covid 19 Scotland dashboard.

Please note: Uptake for those aged 40+ and 50+ were shown previously to reflect the stage of the vaccination roll-out at that time. The vaccination has now been offered to all adults aged 18+

Data and Resources

Additional Info

Field Value
Source Vaccination Management Tool (VMT) and General Practice IT (GP IT), National Records of Scotland, Mid Year Population Estimates 2019 National Records Scotland (NRS) deaths
Author Public Health Scotland
Version 1.0
Last Updated July 30, 2021, 14:03 (BST)
Created January 13, 2021, 10:06 (GMT)
Contact Address Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB
Subject COVID-19, Immunisation
Frequency Daily
Time frame of data and timeliness Vaccination data reported to PHS by 07:30 (GMT), published at 14:00 (GMT) daily.
Coverage Data covering all of Scotland.
Completeness Information presented in this report reflects the data that is sent to Public Health Scotland (PHS). There are known issues with completeness and timeliness of data coming through both routes; this is having a variable impact across health board areas. Work is underway in PHS and with partners to address these issues as part of continuous data quality improvement and assurance processes. Consequently, the information may be subject to change in a future publication, but is presented here as based on the best data currently available to PHS. Data presented in this dashboard represent records available at the date and time of extraction. Covid-19 vaccinations administered in GP practices will have a day lag in the reporting. Please interpret the most recent data with caution. Records without CHI will not be able to deduplicated or attributed to a cohort group and will be excluded from reporting. Public Health Scotland are unable to capture the number of people vaccinated in GP practices for the JCVI priority groups that have been defined using the Vaccine Management Tool (please see JCVI Priority Groups Definitions Table for the definitions used: https://www.opendata.nhs.scot/dataset/covid-19-vaccination-in-scotland/resource/29e8ab8e-065a-4f92-ab70-4371d757633b). This affects the following groups: care home resident, staff working in care homes and any frontline health and social care worker, therefore the number vaccinated within these groups will be a slight undercount. This does not affect the remaining groups, including care home residents -older adults and frontline health and social care workers – specified roles.
Accuracy Information presented in this report reflects the data that is sent to Public Health Scotland (PHS). There are known issues with completeness and timeliness of data coming through both VMT and GPIT routes; this is having a variable impact across health board areas. Work is underway in PHS and with partners to address these issues as part of continuous data quality improvement and assurance processes. Consequently, the information may be subject to change in a future publication, but is presented here as based on the best data currently available to PHS. A small number of vaccinations that took place in GP practices have missing vaccine type and are has been assumed to all be AstraZeneca. Work is underway in PHS and partners to get this missing vaccine type information. Figures are subject to change in a future update as this is resolved. Percent coverage figures are estimates, based on the best information we have available to us. We do not report percent coverage for where we feel that the denominator (total or base) population size cannot be accurately defined.
Continuity of data On 02 December 2020 the UK Government announced the approval of the Pfizer/Biotech COVID-19 vaccine for use. Roll out commenced on 08 December 2020. The AstraZeneca vaccine was also approved for use in the national programme, and rollout of this vaccine began on 04 January 2021. Moderna vaccine was approved for use on 8 January 2021 and rollout of this vaccine began on 07 April 2021. On 26 February 2021, the publication of vaccination data moved from weekly to daily. Geographical breakdowns of data from GP practices that were previously not available in the weekly report are now captured within the daily publication. The vaccination uptake data for non-age based JCVI priority groups is updated on a daily basis to reflect the current population within each group. Data shown is the most up-to-date cumulative total of people vaccinated within each group. Please refer to the table in the JCVI Priority Groups Definitions (https://www.opendata.nhs.scot/dataset/covid-19-vaccination-in-scotland/resource/29e8ab8e-065a-4f92-ab70-4371d757633b) for how these groups have been defined. Individuals who are on the shielding list and are residents of a care home for older adults are updated on a monthly basis. These groups will be updated on the daily dashboard and corresponding open data on the 26th of each month, or Friday before if the 26th falls on a weekend. On 14 May 2021 the calculation of vaccination coverage percentage was changed to reflect the 18+ population as opposed to 16+ for Scotland, NHS Board and Local Authority figures. Numerator and denominator for these calculations is now based on those 18+ only. The overall number of vaccinations and data reported by non-aged based JCVI groups remain as 16+. On Monday 14 June 2021 the 50+ age group reporting for vaccination uptake was changed to 40+. Numerator and denominator data were also changed to reflect this.
Concepts and definitions On 02 December 2020 the UK Government announced the approval of the Pfizer/Biotech COVID-19 vaccine for use. Roll out commenced on 08 December 2020. The AstraZeneca vaccine was also approved for use in the national programme, and rollout of this vaccine began on 04 January 2021. Moderna vaccine was approved for use on 8 January 2021 and rollout of this vaccine began on 07 April 2021. On administration of a vaccine, a record for that individual is recorded in the Turas Vaccination Management Tool (VMT) or via General Practice Information Technology systems (GPIT). A 2-dose schedule is advised for the vaccines. For the Pfizer BioNTech vaccine, the second vaccine dose can be offered between 3 to 12 weeks after the first dose. For the AstraZeneca and Moderna vaccine, the second dose can be offered 4 to 12 weeks after the first dose. As protection is obtained around 14-21 days after the first vaccine dose, the JCVI recommends that vaccinating more people with the first dose is prioritised above offering others their second dose. Number of doses and timing schedule may differ with other vaccination types, which may be rolled out as and when they are developed and approved. Those giving the vaccine to others have been the first to receive the vaccination. In the first phase of the programme, NHS Scotland has followed the independent advice received from the Joint Committee on Vaccination and Immunisation (JCVI) and deliver the vaccine to those with the greatest clinical need, in line with the recommended order of prioritisation. These are: • residents in a care home for older adults and their carers, • all those 80 years of age and over, • frontline health and social care workers, • all those 75 years of age and over, • all those 70 years of age and over, • clinically extremely vulnerable individuals (Clinically extremely vulnerable individuals are described here (https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19). This advice on vaccination does not include pregnant women and those under the age of 16 years (see above) • all those 65 years of age and over, • all individuals aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality, • all those 60 years of age and over, • all those 55 years of age and over, • all those 50 years of age and over. COVID-19 vaccine trials have only just begun in children and data on safety and immunogenicity in this group are, therefore, very limited. Children and young people have a very low risk of severe disease or death due to SARS-CoV-2 compared to adults and so COVID-19 vaccines are not routinely recommended for children and young people under 16 years of age. Vaccine coverage (which may also be referred to as uptake) is defined as the the proportion of individuals aged 18+ from the NRS 2019 mid-year population estimates who have received either 1 or 2 doses of covid-19 vaccine. Recipient age and age group is defined as being the age as at 31 March 2021. Vaccinations by health board and local authority is based on residence and are derived from the recipient's postcode.
Disclosure The PHS protocol on Statistical Disclosure Control is followed.
Revision statement Data is subject to change upon validation. Figures are provisional and are subject to change as records are updated in the Vaccine Management Tool (VMT).
Official statistics designation Management Information Statistics
Format csv
Language English
Links

PHS Weekly COVID-19 Report

COVID-19 Wider Impact Dashboard

Scottish Government – Coronavirus: daily data for Scotland

NHS Inform - Coronavirus (COVID-19) Vaccine

Joint Committee on Vaccination and Immunisation: advice on priority groups for COVID-19 vaccination

Regulatory Approval of Pfizer/BioNTech Vaccine

Regulatory Approval of AstraZeneca Vaccine

comments powered by Disqus